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Abstrak
Latar Belakang: Menurut WHO, dua dari 10.000 wanita di Indonesia hidup dengan kanker serviks dan 
diperkirakan 26 wanita meninggal setiap hari akibat kanker serviks. Berdasarkan kondisi ini, pemerintah 
Indonesia berencana menambahkan vaksin HPV ke dalam program imunisasi nasional. Tujuan penelitian 
adalah untuk menilai kemungkinan kesiapan Indonesia untuk menerapkan vaksin HPV wajib untuk usia 
sekolah dan faktor-faktor yang dapat mempengaruhinya. 
Metode: Metode yang digunakan  adalah systematic review. Melalui artikel terkait vaksin HPV yang terbit 
di jurnal terakreditasi dan scopus-indeks selama 10 tahun terakhir dengan kata kunci “Implementasi 
untuk Imunisasi HPV”, ditemukan sebanyak 17.000 hasil pencarian. Setelah itu, penilaian kritis pada 
artikel yang dipilih dilakukan dengan menggunakan metode PRISMA.
Hasil: Ditemukan bahwa kesadaran masyarakat, terutama orang tua, tentang vaksin HPV masih kurang, namun 
penerimaan mereka terhadap vaksin ini cukup positif. Ada beberapa faktor lain yang menjadi keberatan mereka terhadap 
vaksin, seperti harga tinggi, ketakutan akan efek samping, seksualitas, gender, dan sistem perawatan kesehatan. Saat ini 
di Indonesia vaksin HPV harus dibeli atas inisiatif mereka sendiri dan bukan merupakan program wajib dari pemerintah 
pusat dan juga tidak diberikan secara gratis melalui program JKN. Namun demikian, Kementerian Kesehatan telah 
memulai proyek percontohan untuk menyediakan vaksinasi HPV gratis di beberapa daerah dalam Program Bulan 
Imunisasi untuk Usia Sekolah menggunakan kombinasi sumber daya pusat dan daerah. 
Kesimpulan: Telah ada peraturan dan pedoman teknis untuk pelaksanaan proyek percontohan vaksinasi 
HPV gratis, namun masih perlu penyesuaian dan dukungan dari Pemerintah jika akan dilaksanakan secara 
nasional dan disesuaikan dengan kondisi di daerah dengan fasilitas dan akses terbatas. Dibutuhkan peran 
pemerintah dalam memberikan informasi yang baik tentang vaksin HPV bagi masyarakat. 
(Health Science Journal of Indonesia 2018;9(2):107-18)
Keyword: Vaksin HPV, Kesiapan Implementasi, Program Imunisasi Nasional
Abstract 
Background: According to WHO, two out of 10,000 women in Indonesia live with cervical cancer and an 
estimated 26 women die each day from cervical cancer. Indonesian government is planning to add the HPV 
vaccine into the national immunization program. The objective is to assess the possibility of Indonesia’s 
readiness to implement the HPV vaccine mandatory for school age and factors that may affect it. 
Methods: The method was a systematic review through articles related to HPV vaccine which have been 
published in accredited and scopus-indexed journals for the last 10 years. With keywords “Implementation 
for HPV Immunization”, founded 17,000 search results. Afterwards, a critical appraisal on the selected 
articles is conducted using PRISMA method. 
Results: It is found that the awareness of community, especially parents, about HPV vaccine is still 
lacking, but their acceptance of this vaccine is quite positive. There are other factors into their objection to 
vaccines, such as the high price, fear of the side effects, sexuality, gender, and healthcare systems. Currently 
in Indonesia HPV vaccine must be purchased on their own initiative and is not a mandatory program of 
the central government. Neither has it been given free of charge through JKN program. Nevertheless, 
The Ministry of Health has begun a pilot project to provide free HPV vaccination in some areas within 
Immunization Month for School Age program using a combination of central and regional resources. 
Conclusion: Although there have been regulations and technical guidelines for the implementation of the 
pilot project of free HPV vaccination, it still needs adjustment and support from the Government if it will 
be implemented nationally and adapted to conditions in areas with limited facilities and access. The role 
of the government is needed in providing good knowledge about the HPV vaccine for the community. 
(Health Science Journal of Indonesia 2018;9(2):107-18)
Keyword: HPV Vaccine, Implementation Readiness, National Immunization Program
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Cervical cancer is the second most common type of 
cancer in women worldwide, with all cases linked to a 
sexually transmitted genital infection with the human 
papillomavirus (HPV). Due to poor access to screening 
and treatment services, more than 90% of deaths occur 
in women living in low and middle-income countries.1 
Cervical cancer is the fourth most common cancer in 
women, and the seventh overall, with an estimated 
528,000 new cases in 2012.2 According to the WHO 
(2012), two out of 10,000 women in Indonesia live 
with cervical cancer and an estimated 26 women die 
each day from cervical cancer. The total number of 
women with cervical cancer in Indonesia has reached 21 
thousand cases. Current estimates in 2017 indicate that 
every year, 20928 women are diagnosed with cervical 
cancer and 9498 die from the disease2. Cervical cancer 
ranks as the 2nd most frequent cancer among women 
in Indonesia and the 2nd most frequent cancer among 
women between 15 and 44 years of age.3
It was known that cervical cancer is caused by an 
oncogenic human papillomavirus (HPV) infection. The 
oncogenic HPV types are of 16, 18, 45, 31, 33, 52, 58, 
35, 59, 56, 51, 39, 68, 73, and 82. HPV types 16 and 18 
are the main causes of 70% cases of cervical cancer.4 
In cases of cervical cancer in Indonesia the HPV types 
with the highest prevalence are HPV 16, 18, and 52. 
This virus infects the cervix through sexual contact.5 
HPV virus infection can affect anyone, which ranges 
from women aged 20 years to women who are no 
longer in productive age. Some of the risk factors of 
HPV infection include early age of marriage and sexual 
intercourse at the age of less than 18, and women with 
high frequency of sexual activity and multiple partners, 
smokers, have a history of sexually transmitted diseases, 
parity (the number of births), and long-term use of oral 
contraceptives. These groups face a 5 time greater risk to 
be infected with the HPV virus (human papillomavirus).6,7 
In developing countries, the number of children and 
poverty is a main factor that makes the incident of 
cervical cancer so high.6,7 High risk for women from 
the age of 20 years indicates that adolescence women or 
women who already experienced menstruation should 
start paying attention to her reproductive health. 
WHO recommends a comprehensive approach to 
cervical cancer prevention. The recommended set of 
actions includes interventions across the life course. 
It should be multidisciplinary, including components 
from community education, social mobilization, 
vaccination, screening, treatment and palliative care.8 
Primary prevention begins with HPV vaccination of 
girls aged 9-13 years, before they become sexually 
active. Other recommended preventive interventions 
for boys and girls as appropriate are education 
about safe sexual practices, including delayed 
start of sexual activity; promotion and provision 
of condoms for those already engaged in sexual 
activity; warnings about tobacco use, which often 
starts during adolescence, and which is an important 
risk factor for cervical and other cancers; and male 
circumcision.8 WHO recommends vaccination for 
girls aged 9-13 years as this is the most cost-effective 
public health measure against cervical cancer.8
Immunization is estimated to be able to prevent 2.5 
million cases of child deaths per year worldwide.9 
In Indonesia, immunization is regulated by national 
policy through immunization program. According 
to Minister of Health Regulation No.42 of 2013 on 
immunization implementation, it is mentioned that 
immunization which applied in Indonesia consists of 2 
types that is mandatory immunization and preference 
immunization. Mandatory immunization is an 
immunization given by the government for a person 
in accordance with his / her needs in order to protect 
the concerned and the surrounding community from 
certain infectious diseases, whereas the preference 
immunization is an immunization that can be provided 
to a person in accordance with his/her needs in 
order to protect the affected person from a particular 
infectious disease. Mandatory immunizations consist 
of routine immunization, supplemental immunization, 
and special immunization.10 Categories of preference 
immunization are Haemophilus influenza type b (Hib), 
Pneumococcal, Rotavirus, Influenza, Varicella, Measles 
Mumps Rubella, Typhoid Fever, Hepatitis A, Human 
Papilloma Virus (HPV), and Japanese Encephalitis.10 
Until now HPV vaccine is included in the preference 
immunization category that may not be applied by 
all Indonesians to their children. Although several 
districts/ municipalities in Bali have used APBD for 
free HPV vaccination since a few years ago and so 
did Surabaya using APBD funds, unfortunately, it 
did not take place in all regions in Indonesia.11 Under 
these conditions, the current Indonesian government 
is planning to add the HPV vaccine into the national 
immunization program. The HPV immunization 
program through the Bulan Imunisasi Anak Sekolah 
(BIAS)/Immunization Month for School Age 
program begins with the provision of immunization 
at a pilot site that has a high prevalence rate of 
cervical cancer and is considered to have readiness in 
carrying out HPV immunization. The first place to begin 
the project is DKI Jakarta province starting in October 
2016 and will be continued a year after in two districts 
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in DIY provinces: Kulonprogo and Gunung Kidul 
regencies. DKI Jakarta and DI Yogyakarta provinces 
are the two cities that are considered the most ready for 
the pilot study, and if the project was successful then 
immunization program can be proposed to the National 
Parliament in order to become a national program.11
However, although the HPV vaccine will be 
incorporated into the national immunization program, 
the characteristics and culture of the population in 
Indonesia may not support the ongoing system. This 
study would review the possibility of Indonesia’s 
readiness to implement the HPV vaccine mandatory 
for school age and the factors that may affect it.
METHODS 
Study Design and Sampling Procedure 
The method of this study was a systematic review, 
equipped with secondary data search and sorted the 
relevant news to analyze stakeholder’s statement 
about mandatory HPV Vaccine for school-age 
children. Initial exploration was performed through 
google scholar, ScienceDirect, SemanticScholar 
and Pubmed to find suitable articles using keywords 
“Implementation for HPV Immunization” and 
finding as many as 17,000 search results, then refined 
with more specific keywords. The results then was 
specified with research sites in Indonesia or residing 
in developing countries that have a nearly identical 
characteristics of population with Indonesia. From the 
inclusion criteria were then obtained three articles that 
describe how the views of parents and the community 
on the importance of getting vaccinated at an early 
age performed in India, Indonesia, and Brazil. The 
time period between 2011 and 2016 was applied to be 
able to explore the latest situation. Finally, 5 articles 
matched the criteria and were chosen for the review.
Chart 1. Systematic review process
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Table 1. Articles Characteristic
No Title








of HPV vaccine 
implementation 
among parents in 
India 12
Paul, Proma (2014), 
Health Care Women 
Int Journal; Author 
manuscript; available in 







India Qualitative study Thirty-six interviews 
with parents were 
conducted to assess 
STI-related knowledge 
and HPV specific 
vaccine awareness and 
acceptability
Current vaccine 
utilization,  potential 
barriers to receiving 
existing and new 
vaccine, knowledge 
of HPV and related 
diseases.
Participants were 
asked about the 
current immunization 




infection, genital warts, 
and cervical cancer 
was assessed
2 “Those Who Love, 
Vaccinate”: Parental 
Perceptions Of HPV 
Vaccination 13
Chiang EDO 
(2014), Journal of 








to vaccinate their 
daughters against 
HPV
Brazil Qualitative study Thirty semi-structured 
interviews were 
conducted at five health 
posts in São Paulo, 
Brazil. Interview 
questions explored 
parental opinions of 
disease prevention 
methods, vaccines in 




questions on six major 
themes. These questions 
explored parent 
opinions of disease 
prevention methods, 
the HPV vaccine, and 
vaccines in general, 






preserving health, Trust 
in Health professional
3 Parental Acceptance 
Of Human 
Papillomavirus 
(HPV) Vaccination In 
Indonesia: A Cross-
Sectional Study 
Jaspers (2011), Vaccine 
Journal, Volume 
29, Issue 44, 13 













746 parents, with at 
least 1 daughter aged 
0–14, were interviewed 
using questionnaires 
based on published and 
adjusted interviews. 
Interviews were done 
in sub district public 
health centers, general 
governmental hospitals, 




Knowledge and sources 
information, fact sheet, 
attitudes towards 
vaccination in general, 
health beliefs regarding 
cervical cancer, HPV 
vaccine acceptance and 
reason in favor and 
against, other factors 
and possible barriers
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No Title




Subject and Study 
Sample
Variable
4. Parent and 
adolescent 
knowledge of HPV 
and subsequent 
vaccination.











is related to 













of HPV and HPV 
vaccination, as well 
other variables, were 
completed by 211 
adolescents and 149 
parents of another 
adolescent sample
Knowledge of HPV and 
HPV vaccination,
5 Attitudes and 
perceptions towards 
HPV vaccination 
among young women 
in Saudi Arabia
Hussain, Anella et all 
(2016)
J Family Community 





the awareness of 
HPV infection, 
its health sequel 
and the attitude 
and barriers to 
the acceptance of 
HPV vaccine by 
young women in 
Saudi Arabia
Saudi Arabia Quantitative 
study
All patients of Family 
Medicine department, 
King Faisal Specialist 
Hospital and Research 
Center, Riyadh were 
invited to participate in 
this study from January 
2012 to June 2014. A 
total of 325 patients 







After the results were sorted into 5 (five) journals, 
then the analysis of the significant variables that 
affect the decision of parents in vaccinating their 
children with HPV and how the recommendations 
were applied in the country was conducted. The 
readiness of implementation of this policy then was 
analyzed using the Edward III Framework(1980), 
equipped with secondary data search, and analysis 
of relevant news in mass media as a form of 
triangulation to maintain the validity of data. This 
study wanted to identify what kind of efforts have 
been done and should be done by the government of 
Indonesia in supporting the implementation of HPV 
vaccine policy. From that point of view, it can be 
figured out how Indonesia’s readiness to implement 
the HPV vaccine mandatory for school-age children.
 
RESULTS 
The study conducted in India with a qualitative 
approached and complimented with quantitative data 
analyzing, have found that based on demographic 
data, the participants were between 19–62 years old 
(average 30) and the majority were mothers (83%) 
and Hindu (81%). Education ranged from none to 
postgraduate degrees and most (67%) were employed. 
The study found that, there was lack of knowledge of 
the respondent, only two respondents reported to have 
some knowledge of HPV. All but seven participants 
had heard of cervical cancer; however, only one 
knew cervical cancer was associated with Sexual 
Transmitted Infection. Overall, parents understood 
that vaccinations were important but several parents 
were unaware of the need for vaccines to be given 
at older ages. Moreover, none of the participants 
knew about the HPV vaccine. Despite of the lack 
of of knowledge related to HPV and the associated 
vaccine, most parents were willing to vaccinate 
their children against HPV, especially with a health 
worker recommendation.12 
From the perspective of who will be given the 
vaccine, many parents reported acceptance of girls-
only vaccination. Others, however, indicated that the 
vaccine would only be acceptable if it was given to 
both girls and boys. All parents reported they would 
vaccinate their children if the vaccines were free, 
while 18 parents reported willingness to pay. Primary 
obstacles to vaccination were related to missing 
work for vaccine appointments and associated costs. 
Although vaccines were free (or low-cost) the family 
still lost daily wages because of waiting or going to 
the health care center to take a HPV vaccination for 
Health Science Journal of IndonesiaAyuningtyas and Sutrisnawati112
their children. Overall, the most common barriers 
to HPV vaccination were work, cost, the concern 
about side effects, and education about HPV vaccine 
(e.g., effectiveness, karma). There was little concern 
related to transportation as most of the clinics were 
nearby or health workers came to the village.12
Similarly, the study in Brazil found the result that 
the knowledge of HPV was low among all parents 
(The participants were mainly female (87%) and 
the average age of the parents was 38 years and 
many had 1-2 children (46.7%)). However, a lack of 
knowledge did not determine support for vaccination. 
The interviews reflected a prominent culture of 
vaccination, where the decision to vaccinate appears 
to be less of an independent decision and more of 
a cultural expectation. Previous positive experiences 
with vaccination, including childhood vaccinations, 
perpetuate current positive perspectives of 
vaccines and subsequently, and the normalization 
of vaccination. The majority of parents expressed 
their reliance on the healthcare professionals in the 
health posts for their health related questions. Trust 
in biomedicine extends to trust in the Ministry of 
Health and its guidelines.13 
Perceived gender differences within the realm of 
health and sexuality contributed to the acceptance 
of HPV vaccination for both boys and girls. High 
rate of acceptance for the vaccine also contributed 
to the sense of responsibility among parents for 
both maintaining their child’s health and making 
their healthcare decisions. This study suggests 
that parental decisions to vaccinate against HPV 
can be better understood by examining the culture 
of vaccination from which the vaccine gains more 
than just a biomedical identity. HPV knowledge 
levels are not predictive of parental decisions to 
vaccinate daughters. Context specific factors from 
the sociocultural dimensions of parenting, sexuality, 
gender, and the healthcare system are more influential 
in vaccine decision-making.13
On another note, results from the study in Indonesia 
maybe quite interesting because of the diverse 
sociodemographic. Participants came from more 
than 23 different ethnical backgrounds. The highest 
percentage of Muslims was found in Surabaya 
(98.7%) and Banjarmasin (97.4%), the highest 
percentage of Hindus was found on Bali (88.4%), 
and the highest percentage of Christians was found 
in Manado (84.6%). In Medan 73.6% were Muslims 
and 26.4% were Christians. Furthermore, the 
vaccination status of children in Medan (77.4%) and 
Banjarmasin (83.6%) was lower than in the other 
regions (p < 0.001). A lower education level of the 
parent also leads to a lower vaccination status of 
their children (p < 0.001).5
In addition, knowledge of HPV, HPV vaccination, 
and cervical cancer was low, inferred from three 
hundred and seven (41.6%) of the participants had 0 
answers correct and only 30 participants (4.1%) had 
the maximum score of 8. The majority of the parents 
stated that they would like to learn more about these 
topics. In general, participants had (very) positive 
attitudes towards vaccination. Slightly fewer than 
40% were afraid for the side-effects of vaccines 
and nearly 35% believed vaccination should only 
be given for very severe diseases. Health beliefs 
regarding cervical cancer showed that nearly 100% 
of the participants agreed that cervical cancer 
was either a very severe or severe disease; nearly 
100% of the participants were either very afraid 
or afraid that their daughter(s) would develop 
cervical cancer in the future. Furthermore, 96.1% 
participants would accept HPV vaccination for 
their own daughters.5 
The acceptance rate of immunization in the 
five provinces is as follows: Surabaya (98.7%), 
Bali (97.7%), Manado (96.0%), Banjarmasin 
(95.7%), and lastly Medan (92.5%). Due to the 
high acceptance rate, people who were in favor 
of HPV vaccination were also asked for their 
hypothetical reasons against vaccination. Ethnicity 
and HPV vaccine acceptance were found to be 
significantly associated. People from a Malay or 
Batak background (who both live in the provinces 
of Medan, Sumatra), were more negative towards 
HPV vaccination of their children. The Javanese 
and Balinese were more positive. Province by itself 
was not statistically significant. 
Regression revealed that age, health beliefs about 
cervical cancer score, and the attitudes towards 
vaccination in general, were the only significant 
factors. Participants who were in favor of HPV 
vaccination were younger than those against HPV 
vaccination. Positive attitudes towards vaccination 
in general and positive health beliefs about cervical 
cancer also lead to a higher HPV vaccine acceptance 
rate. HPV vaccine acceptance was higher for 
participants with a higher total knowledge score, 
and for participants of whom the children received 
all the recommended vaccinations according to the 
national vaccination program.5 
The high acceptance rate of immunization found in this 
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study could be explained by different reasons. Firstly, 
routine national immunization schedules are extensive 
in Indonesia, and parents are used to having their 
children vaccinated. Secondly, for many respondents 
their participation in this survey was their first contact 
with the topics HPV and HPV vaccination, Thirdly, 
the positive response towards HPV vaccination could 
be explained because participants gave the answer 
they thought would be the most socially desirable, 
instead of giving the answer they truly wanted to give. 
In Indonesian culture, this phenomenon is seen more 
frequently. 
In this study possible barriers towards HPV vaccine 
acceptance were found, such as the cost of the 
vaccine, the fear for possible side-effects could form a 
possible barrier, and also the preferred location where 
participants would like to go for HPV vaccination 
differed. Most of the participants would prefer to go 
to a Puskesmas (sub district public health center) to 
get their children vaccinated to public hospitals. The 
reason why most participants of this study would 
prefer to go to the Puskesmas for HPV vaccination 
is because they belong to the group of people with 
a low or middle income. They are the ones that use 
the Puskesmas as their primary health care facility. 
Therefore, vaccination locations should be taken 
into account when planning strategies to implement 
HPV vaccination on a large scale in Indonesia.5
DISCUSSION
From the five studies above, it is found that the 
parent’s knowledge about HPV, cervical cancers 
and HPV vaccine are still low, but their acceptance 
of this vaccine is quite positive. On the other hand, 
HPV knowledge levels are not predictive of parental 
decisions to vaccinate daughters. This is similar 
to the opinion of Fishman et al14 according to the 
results of his research which states that, although it 
is conceivable that knowledge is a prerequisite of 
healthy choices, it has been unclear if knowledge is 
indeed related to HPV vaccination. Neither parental 
nor adolescent knowledge was related to adolescent 
vaccination, as measured objectively at prospective 
time points. Some with low knowledge did get 
vaccinated and others with high knowledge did not 
get vaccinated. This finding suggests that, for many, 
knowledge was neither necessary nor sufficient.14 
Another research conducted by Hussain found that, 
although the proportion of participants who had prior 
knowledge of HPV vaccine was low, the majority of 
participants consented to initiate the HPV vaccine 
series.15 This was predominantly the result of their 
physician’s encouragement and the free availability 
of vaccine. Therefore, the health care providers are 
a quintessential source of education and advocates 
of this relatively new vaccine.14 Primary health care 
physicians, pediatricians, and nurses are all crucial 
in educating and encouraging patients to initiate and 
complete the HPV vaccine series. Physician-patient 
encounter may also be used as a platform to deal 
with the commonly cited concerns of parents who 
decline the vaccine.16 
From the results obtained in India, many parents 
reported acceptance of girls-only vaccination while 
others indicated that the vaccine would be acceptable 
if it was given to both girls and boys. Parents consider 
sex and gender in giving HPV vaccine to their 
children. This is also still a consideration in some 
countries, some have implemented Gender-Neutral 
policies such as Australia, US, and Canada for the 
provision of  HPV vaccine for both boys and girls, 
but some countries such as the UK, budget problems 
still into a major consideration in giving HPV vaccine 
for all of the children. The basis of gender-neutral 
application is the fact that even though men are at 
low risk, but if he is a homosexual who had a sex with 
men, may be at higher risk than girls.17 Important 
possible benefits from male immunization include 
significantly reducing or eliminating transmission 
of the virus in the population, thereby protecting the 
non-immunized, and the benefits from preventing 
HPV disease in males, which is not insignificant.18 In 
addition, the factors which may affect the acceptance 
rate of HPV vaccine is age, health beliefs and attitude 
toward the immunization. Other things that may be 
a parent consideration to give HPV vaccine to their 
children one of them is the price charged for the 
vaccine. Without a doubt, one of the greatest barriers 
to the introduction of the HPV vaccine is its price.19 
The process to include HPV Vaccine into the national 
immunization program in Indonesia will certainly 
be a fairly long discussion considering the price of 
HPV vaccine package is quite expensive. However, 
if viewed from a cost-effective perspective this 
certainly should be a more appropriate approach 
compared to the risk of cervical cancer-affected 
generation. In developing countries, HPV vaccines 
are not offered as part of the national immunization 
schedules. Immunization costs are not covered and 
vaccine uptake may be determined by the market 
(and marketing). Mandatory HPV immunization, 
although effective, would strain the health budgets 
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of developing countries.20 The GAVI Alliance 
(formerly known as the Global Alliance for Vaccines 
and Immunization) — a partnership of national 
governments, the World Health Organization, the 
World Bank, the Bill and Melinda Gates Foundation, 
the vaccine industry, public health institutions, 
and non governmental organizations — provides 
technical assistance and financial support for 
vaccines in countries with a gross national income 
of less than $1,000 per capita, as well as in China, 
India, and Indonesia.19. This partnership can be an 
alternative solution to the funding problem.
All of the research above stated that, more positive 
health beliefs of the parents will have an impact on 
the increased acceptance rate of HPV vaccine. This 
statement in accordance with research from Emily 
L. B. Lykins, M.S., et al), who stated that beliefs are 
influenced by personal experience of a disease that 
affects the acceptance of messages and interventions 
to perform risk-prevention behaviors of a disease, in 
this case cancer.21 Attitudes towards general health, 
vaccinations in general, as well as HPV vaccines 
are important in HPV vaccine uptake.22 Factors that 
form attitudes, such as the experience of parents and 
families about cervical cancer, can give a support 
to the respondents to prevent cervical cancer. This 
is consistent with Azwar, who stated that there are 
several factors that influence a change in a person’s 
attitude: personal experience, other important 
person’s influence, cultural influence, mass media 
influence, education and emotional.23
Currently in Indonesia HPV vaccine is still included 
in the preference immunization category that may not 
be applied by all Indonesians to their children. The 
vaccine must be purchased on their own initiative, not 
a mandatory program of national governments and 
has not given free of charge through JKN program. 
The services provided are merely early detection 
through visual inspection methods acetic acid (VIA) 
or pap smear tests for participants BPJS.  However, 
the current Indonesian government is planning to 
add the HPV vaccine into the national immunization 
program.11 The pilot project to give a free-cost 
HPV immunization for school age children was 
conduct in DKI Jakarta on October 2016 and in DI 
Yogyakarta will conduct on 2017, through the Bulan 
Imunisasi Anak Sekolah (BIAS)/Immunization 
Month for School Age program. The government is 
implementing the provision of HPV immunization to 
female students of grade 5 (first dose) and 6 (second 
dose) of elementary school / Madrasah Ibtidaiyah 
and equal to both state and private school. For 
pilot program in DKI Jakarta and Yogyakarta, the 
central government cooperates with GAVI (Global 
Alliances for Vaccine and Immunization). After this 
pilot project, the government will review that if the 
project was successful then immunization program 
can be proposed to the National Parliament in order 
to become a national program and the funding source 
for the vaccines comes from APBN (Anggaran 
Pendapatan Belanja Negara/State Budget Revenue).11
In Indonesia, an ineffectiveness of policy 
implementation is quite often due to a lack of 
coordination and cooperation among states and/
or government institutions. Even though the 
implementation is a crucial stage in the policy 
process and without effective implementation, the 
decision of the policy maker will not be successfully 
implemented.24,25 Implementation of a policy is an 
activity that is visible after a legitimate directive 
is issued from a policy that includes managing 
inputs to produce outputs or outcomes for the 
community. According to George Edward III (1980) 
in Nugroho (2009) states four things that drive policy 
implementation into success as follows25:
a. Communication
Related to how the policy is communicated to the 
organization and/or the public, the availability 
of resources to implement the policies, attitudes 
and responses of the parties involved, and 
how the organizational structure of the policy 
implementer. Indonesian Government need to 
ensure the policy communication system between 
the Ministry of Health and the units of the Public 
Heath Office (PHO) which is then downgraded to 
Puskesmas in the region runs well and smoothly, 
even if it is necessary to maintain cross-sectoral 
communication. There needs to be coordination 
and intensive meetings to keep the socialization 
of the policy well received up to the smallest unit 
of society. Socialization media must also be used 
effectively, considering the results of research 
in some areas in Indonesia stated that the level 
of public knowledge about HPV vaccine is still 
low. During this time the Ministry of Health is 
actively providing the correct information related 
to the HPV vaccine implementation in school-
age children. For example, there is fear from the 
parents about alleged side effects of vaccines that 
lead to early menopause. This information is then 
denied and straightened out through various media, 
for example articles published by the Bureau of 
Communication and Public Services, Ministry of 
Health through Ministry of Health’s web.11
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The same situation of controversies occurred 
recently in India over implementation of HPV 
vaccine studies (e.g., adverse event/side effects) 
resulting in the suspension of these projects.12 
These unfortunate events highlight the need for 
Indian health authorities and government officials 
to address people’s concerns clearly and quickly 
to dispel fears based on misinformation and focus 
on improving the informed consent process.12 
In Indonesia, the implementation of HPV 
immunization within the Immunization Month for 
School Age program (BIAS) has been regulated 
through the Decree of the Minister of Health of 
the Republic of Indonesia No. Hk.02.02 / Menkes 
/ 489/2016 on Implementation of Immunization 
of Human Papilloma Virus in the DKI Jakarta and 
Daerah Istimewa Yogyakarta. This regulation is 
issued to regulate the implementation of pilot 
projects in 2 major cities in 2016 and 2017, and 
not yet applicable to implementation all over 
Indonesia. This regulation then disseminated 
to the implementers and stakeholders involved 
to facilitate the implementation of activities. 
In addition, there is also a technical guidance 
of implementation designed by the Ministry 
of Health to make the implementation more 
effective. 
Moreover, the government needs to prepare 
adequate funds and facilities related to the 
implementation of free HPV. If the funds are 
approved to be included in the state budget, then 
vaccine-cost is no longer a barrier in parents’ 
consideration of giving vaccines so that every 
child in Indonesia can get this vaccine. 
b. Resources
This is related to the availability of support 
resources, especially human resources, 
more specifically  the skills of public policy 
implementers to carry out the policy effectively. 
Training and dissemination of HPV vaccine and 
its delivery procedures need to be provided to 
officers to ensure that even in the smallest units, 
health worker can provide good information to the 
parents. Front line physicians and educated men 
(though not health workers) in every environment 
can be important stakeholders in HPV vaccine 
acceptability and involve in the community as 
group or opinion leaders to transport awareness 
on vaccines in general as well as on HPV vaccine 
in particular.16 In the Technical Guidance for 
the implementation of HPV Immunization 
issued by Ministry of Health in 2016 to support 
the implementation of pilot project in two 
regions; DKI Jakarta and Yogyakarta, there is a 
statement explained that for the implementation 
of immunization in elementary school children 
are equally implemented in an integrated manner 
by cross-program and cross-sectoral in terms of 
personnel, facilities and funds from the central 
level to the executing level. While in detail for 
the needs such as all vaccine needs, syringes and 
safety box are charged to the National Budget, 
while the needs of immunization cards of school 
children, report format, anafilactic equipment, 
and operational costs are charged to District 
Budget. 
The design of funding system and the needs 
fulfillment was done on two big cities or areas 
in Java. However, the discussions will be more 
complicated considering this design on the islands 
of the archipelago with inadequate fiscal means 
and capacity by charging the District Budget. In 
addition, if the HPV vaccine is incorporated into 
a national immunization program, it should also 
be noted that the provision of state budget funds 
have to meet vaccine needs for all school-aged 
children in all regions of Indonesia.
c. Disposition or policy implementation attitude
Related to the willingness of the implementors to 
carry out such public policies. Skills alone are not 
enough without the willingness and commitment 
to implement the policy. Commitment of health 
service and stakeholder in community health 
clinics can be maintained with clear regulation 
related to this HPV vaccine. Regulations 
governing the role of stakeholders and vaccine 
delivery procedures will keep the implementation 
of the policy on track. Multi-sectoral roles and co-
operation can also makes policy implementation 
runs well.
Government’s support is vital in encouraging 
HPV vaccine to become mandatory immunization 
for all children in Indonesia. Although clinically, 
HPV vaccine is highly recommended for every 
child, but bureaucratic problems within a country 
can be a polemical things in determining the 
policy of whether HPV vaccine will be included 
in the national immunization program or not. A 
contrast opinion that is mentioned by Javit et al, 
while the emergence of an HPV vaccine reflects 
a potentially significant public health advance, 
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the vaccine raises several concerns.26 First, 
the long-term safety and effectiveness of the 
vaccine are unclear. Second, the legal and ethical 
justifications that have historically supported state 
mandated vaccination do not support mandating 
HPV vaccine. Mandating HPV would therefore 
constitute an expansion of the state’s authority to 
interfere with individual and parental autonomy. 
Engaging in such expansion in the absence of 
robust public discussion runs the risk of creating 
a public backlash that may undermine the goal 
of widespread HPV vaccine coverage and lead to 
public distrust of established childhood vaccine 
programs for other diseases. Third, the current 
sex-based HPV vaccination mandates present 
constitutional concerns because they require only 
girls to be vaccinated. Such concerns could lead 
to costly and protracted legal challenges. Finally, 
vaccination mandates will place economic 
burdens on federal and state governments 
and individual practitioners that may have a 
negative impact on the provision of other health 
services.26 Although public health officials have 
recommended that all girls aged 11 or 12 be 
vaccinated for HPV—a sexually transmitted 
virus that causes cervical cancer—political 
controversy has blocked adoption of mandatory 
school-enrollment vaccination programs in all 
but one state.27
Quoted from Media Indonesia (January 22, 2018), 
the member of the Legislative Assembly; Irma 
Chaniago, stated that the Legislative especially 
Commission IX support and encourage HPV 
vaccine to get into the national immunization 
program. This has been done from 2015 and 
all fractions in the parliament have agreed. The 
Legislative Assembly considers that the cost for a 
nationwide HPV vaccination program is smaller 
than the impact of illness. Moreover, in some area 
in Indonesia does not have the chemotherapy 
facilities that cervical cancer patients need. They 
hoped that HPV vaccination pilot project in school 
children in Jakarta, Yogyakarta and Surabaya can 
be extended to other areas so that after 2019 HPV 
vaccine has become a national program.28
The introduction of HPV immunization has also 
been planned for a long time by the Government, 
which has been stated in the comprehensive Multi 
Year Plan (cMYP) of 2015-2019 immunization 
program. The introduction of HPV immunization 
into the national immunization program 
was carried out in stages, starting with the 
implementation of pilot project in DKI Jakarta in 
2016, then this year expanded to 2 (two) districts 
in DIY Province namely Kulonprogo and Gunung 
Kidul Regency and Surabaya City (Ministry of 
Health, 2017). For the implementation of this 
introduction is also regulated through the Decree 
of the Minister of Health of the Republic of 
Indonesia No. Hk.02.02 / Menkes / 489/2016 
on Implementation of Immunization of Human 
Papilloma Virus in DKI Jakarta and Daerah 
Istimewa Yogyakarta.
Ministry of Health also provides a Technical 
Guide to Implementation of HPV Implementation 
in Immunization Month of School Age (BIAS) 
issued in 2016, which explained about the role 
and function of each level either from the Central 
Ministry, Provincial, District / Municipal Health 
Office and Puskesmas. In addition to involving 
health agencies there is also multisectoral 
cooperation with the ministry of education and 
culture also the education offices at the district / 
municipal level, the Ministry of Religious Affairs 
and its staff and the Ministry of Internal Affairs in 
coordination with the Provincial Government and 
District / City Government.29
d. Bureaucratic Structure
Related to the suitability of the bureaucratic 
organization which is the organizer of the 
implementation of public policy. Providing HPV 
vaccine that is planned to be given in conjunction 
with the school immunization month program 
can simplify the procedure, because the existing 
bureaucratic structure will follow a pattern that 
has been going well before.
Implementation of BIAS in Primary Schools / 
Madrasah Ibtidaiyah of both public and private 
in Indonesia is the result of mutual cooperation 
and coordination. BIAS activity is one of the 
health services activities included in the Trias 
Program of the School Health Unit / Community 
Health Unit which is the provision of health 
services involving the Ministry of Health, the 
Ministry of National Education, the Ministry 
of Religious Affairs and the Ministry of Home 
Affairs. BIAS involving all levels, starting from 
National, Provincial, District / Municipal level 
to Sub-district level so that the health sector 
always coordinate with the Team of Trustees 
and the School Health Unit / Community Health 
Unit Implementation Team. The implementation 
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of guidance and development of School Health 
Unit / Community Health Unit is implemented 
by the Ministry of National Education, Ministry 
of Health, Ministry of Religious Affairs, and 
Ministry of Internal Affairs either individually 
or jointly in accordance with their duties and 
functions, which has been established by the 
Joint Decree between the Minister of Education 
and Culture Health, Minister of Religious Affairs 
and Minister of Home Affairs in 2014. These 
four Ministries are hereinafter referred to as the 
School Health Unit / Community Health Unit 
Fostering Team that control the School Health 
Unit / Community Health Unit at the Central, 
Provincial, District / Municipal and District 
levels.29
Technically, at the beginning of the school year, 
public health officers ask for data on the number 
of school children of Primary Schools especially 
in grades 5 and 6 to the District / City Education 
Office and Regency / City Religious Offices. 
Immunization then was done in school and if 
there is an ill student, they will be given a letter of 
introduction from the school to get immunization 
later at the nearest health center. Immunization 
records and report, vaccines, logistics, vaccine 
chains, and post-immunization follow-up 
incidents (KIPI) are sent gradually from the 
Public Health Offices to the Center with copies 
to the School Health Unit Development Team at 
each level. 29
A detailed and clear support structure will 
make policy implementation effective. Design 
structures such as those designed for BIAS, 
especially pilot projects in some areas for HPV 
immunization can be adapted to facilitate future 
implementation. The system of giving through 
schools can also make it easier for parents so they 
do not have to lose their work time just to get 
their children vaccinated. However, an alternative 
needs to be arranged for children in areas with 
low school-entry levels. Whether the door to door 
system would be better implemented still needs 
to be re-examined.
Consideration of this matter will surely be a 
long discussion, but of course it is expected that 
the Government’s plan to put HPV vaccine into 
national immunization program, as well as its policy 
implementation, can run as planned. This will 
certainly be a major step of the Indonesian nation to 
keep away the generations from cervical cancer and 
reduce the death cases from this disease.
In conclusion, the information and analysis 
from systematic reviews, secondary data, and 
stakeholder’s statement which stated in relevant 
news can be concluded that, although knowledge 
is not a determining factor, the government needs 
to raise people’s awareness about the HPV vaccine 
through a variety of media to encourage them to get 
the HPV vaccine from an early age. Health belief and 
attitude toward immunization also can be influenced 
by a good role of the Primary health care physicians 
in educating and encouraging patients to initiate and 
complete the HPV vaccine series. Government needs 
to support this program with a good communication 
and socialization system, by providing a clear 
regulation related to this HPV vaccine, and making 
sure the required resources are available, especially 
the funding resources for the implementation.
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